Editas Medicine Inc. (EDIT) at a glance

Editas Medicine Inc. (EDIT) is a small-cap Healthcare company. It trades at $3.18, with a -281.6% profit margin and revenue decline of 39.2%. It does not pay a dividend. Vestovix scores it 26/100 overall. Its strongest dimension is Momentum (52/100) and its weakest is Growth (11/100). It carries above-market volatility, so expect larger swings.

Price

$3.18

Market cap

$383.7M

P/E ratio

n/a

Dividend yield

None

Beta

2.10

52-week range

$1.66 to $4.54